Sam Hornblower

News from my colleagues @RobertLangreth & @SamHornblower : Former biotech executive George Tidmarsh will be the FDA's new top drug regulator bloomberg.com/news/articles/…

The biotech veteran was involved in the development of several approved drugs, likely making him a reassuring choice for a pharmaceutical industry that’s facing pressure from the Trump administration to lower prices and move drug manufacturing to the US bloomberg.com/news/articles/…

A dispatch from the trade war (they’re coming for your wine cellar) youtube.com/shorts/jZbOOcu…

The FDA has begun sharing rejection letters sent to pharmaceutical companies when turning down their drug applications. It started with 200 medicines that were subsequently approved. Get more, including an exclusive interview with Makary, here: bloomberg.com/news/articles/…

This week, Wall Street Week's David Westin spoke with FDA Commissioner Marty Makary, with corn farmers in Iowa about the export markets they need to make their business work bloomberg.com/news/newslette…

Under new leadership from Dr. Marty Makary, the FDA is undergoing sweeping reforms to restore public trust, prioritize transparency and modernize drug oversight. Learn more about his approach on tonight's "Wall Street Week" at 6 p.m. ET bloom.bg/44NT0wH

@SamHornblower Watch Makary's full interview with @DavidWestin on @BloombergTV's Wall Street Week tonight at 6pm ET. bloomberg.com/btv/series/wal…

@rachelcohrs @damiangarde youtu.be/a8kaKxy8K5A?si…

News: The FDA plans to publish rejection letters describing why medicines aren't approved that companies have mostly kept hidden until now via @damiangarde + @SamHornblower bloomberg.com/news/articles/…

@rachelcohrs @damiangarde bloomberg.com/news/videos/20…

The new head of the FDA says the agency was wrong to approve OxyContin for chronic pain — and cited a Bloomberg investigation as evidence bloomberg.com/news/newslette…

Armed with a pistol and a cane, Brig. Gen. Theodore Roosevelt Jr. landed with the first wave at Utah Beach on D-Day. This is the epic story of the first General to land on D-Day, who was also the son of a U.S. President. 🧵

Just produced this two-part story on undersea cables for Wall Street Week — Part 1 looks at the U.S.–China tech war, Part 2 dives into how hyperscalers are building the internet’s backbone for AI and cloud.

Just produced this two-part feature on undersea cables for Wall Street Week — Part 1 looks at the U.S.–China tech war, Part 2 dives into how hyperscalers are building the internet’s backbone for AI and cloud.

An investigation into the FDA's repeated violations of its own rules to approve addictive drugs—and its ongoing failure to rein in the public-health crisis bloomberg.com/news/features/…

An investigation into the FDA's repeated violations of its own rules to approve addictive drugs—and its ongoing failure to rein in the public-health crisis bloomberg.com/news/features/…

The inside story of how the FDA broke its own rules and played a part in one of the deadliest public health disasters in American history. Read more from Bloomberg’s Businessweek and watch "Wall Street Week" tonight at 6 p.m. ET bloom.bg/4lMkwCr

Several years ago, I reported on the opioid epidemic for 60 Minutes. One question stayed with me after I left: what happened inside the FDA? I went looking for the missing thread. Here’s what I found.

Great investigative reporting from @SamHornblower examining #FDA review (and lapses in the process) that contributed to the #OpioidCrisis. Many #Opioid #Archive docs referenced. An important read as policymakers consider next steps for #opioid #policy and approval of other drugs.

We've blamed pharma companies for the Opioid crisis - Purdue, J&J and the rest. But what was the FDA's role? And what will weakened health agencies mean for the next public health crisis? Powerful, epic story from @samhornblower in @BW and on this week's @BloombergTV Wall Street Week: bloomberg.com/news/features/…